Heart Test Laboratories Inc. Warrant

HeartSciences Inc. is a medical technology company focused on advancing electrocardiography (ECG) through artificial intelligence. It develops AI-enhanced ECG (AI-ECG) solutions, including an algorithm to detect impaired cardiac relaxation or cardiac dysfunction, the MyoVista wavECG resting 12-lead ECG device that provides diagnostic information on cardiac dysfunction alongside conventional ECG information in the same test, and MyoVista Insights, a cloud-native, vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. It was incorporated in 2007 and is headquartered in Southlake, Texas.